Johnson & Johnson Confronts Major Legal Battle in U.K. Over Talcum Powder Asbestos Allegations

Thousands of individuals in the U.K. have lodged a massive legal claim, valued at over one billion pounds, aiming at the U.S. pharmaceutical giant Johnson & Johnson. They accuse the company of knowingly distributing baby powder containing cancer-causing asbestos.

The case includes more than 3,000 individuals diagnosed with various cancers and other ailments. Their argument is substantiated by internal communications from Johnson & Johnson and scientific evaluations.

In the United States, Johnson & Johnson has also been entangled in numerous similar lawsuits. Despite some legal victories, they agreed in June of the previous year to a national settlement addressing claims that they misled consumers about the safety of their talcum products.

Last week, a decision by a Los Angeles court required Johnson & Johnson to compensate the family of a deceased cancer patient who had used their products.

The British lawsuit spans the years between 1965 and 2023, asserting that for over five decades, Johnson & Johnson knew their talcum goods contained hazardous asbestos and prioritized profits over consumer safety.

According to the lawsuit, the company only transitioned to a cornstarch-based formula and withdrew its talcum powder from U.K. shelves in 2023, lagging three years behind similar actions in the U.S. and Canada.

"Johnson & Johnson orchestrated a calculated campaign of denial," stated Tom Longstaff of KP Law, representing the claimants in the U.K. legal system. "The evidence is indisputable that contaminated talcum products pose a carcinogenic threat, and Johnson & Johnson understood this hazard."

Longstaff further emphasized the gravity of the corporate misconduct, vowing to hold the company accountable for the widespread suffering it allegedly caused.

Johnson & Johnson rejects all claims of wrongdoing, maintaining they were unaware of any asbestos contamination in their products.

Their official statement insists their baby powder complies with regulatory norms and is free from asbestos-related health risks.

Talc is a naturally occurring mineral commonly co-located with asbestos in mines, complicating efforts to produce asbestos-free talcum powder.

Victims allege that prolonged exposure to Johnson & Johnson's talc resulted in a host of diseases, including ovarian cancer, mesothelioma, and other severe illnesses.

"Both my mother and I used the talc," said Siobhan Ryan, 63, expressing shock upon learning of her stage-four ovarian cancer diagnosis. "The scent was pleasant, and I thought it was beneficial for my children when they were infants."

Siobhan attributes her cancer to Johnson & Johnson's talcum powder, having endured arduous treatments involving chemotherapy and life-threatening medical crises.

She expressed her dismay over Johnson & Johnson's supposed cognizance of the contamination yet continuing to market the product to new mothers.

According to lawsuit records, the pharmaceutical company commenced having its talc scrutinized by scientists since the 1960s. A 1969 document noted that the use of tremolite, an asbestos form, should be minimized until deemed harmless, acknowledging talc's unsuitability for infants.

Acknowledgment of asbestos' cancer-causing potential became widespread by the 1980s, yet Johnson & Johnson, alongside other corporations, successfully lobbied against regulatory controls over asbestos content in talc.

The FDA started examining talcum powders for asbestos in 2018, and after discovering traces in 2019, Johnson & Johnson conducted a product recall.

Decisions in the U.K. claims will be rendered by a judge, not a jury, within the Manchester Circuit Commercial Court.

Johnson & Johnson believes the judge will determine that their talcum products were not carcinogenic, as stated by the company's representatives.